Meet Dani Feldmann

Dani Feldmann

Within EVOLF, my project focuses on developing Craspase as a transcriptional regulator in a synthetic cell. Our goal is to explore how Craspase can precisely time critical cellular processes, like cell division, by leveraging its RNA-sensing and protease activities.

Hi, my name is Dani Feldmann. I recently joined the EVOLF consortium as a PhD candidate in the Brouns Lab at the TU Delft. This return to the TU Delft is a familiar one, as I completed both my Bachelor’s  and Master’s degrees in Nanobiology here.

During my Master’s, I grew increasingly interested in microbiology, and in CRISPR in particular. I had the opportunity to work on a unique CRISPR system, called Craspase, which had recently been characterized within the Brouns Lab. Craspase acts as a programmable, RNA-sensing protease, holding promising potential in synthetic biology, therapeutics, and other related fields.

Within EVOLF, my project focuses on developing Craspase as a transcriptional regulator in a synthetic cell. Our goal is to explore how Craspase can precisely time critical cellular processes, like cell division, by leveraging its RNA-sensing and protease activities. Through this work, we aim to make a meaningful contribution to the synthetic cell division module.

In my spare time, I enjoy travelling, fitness and cooking questionable dishes. I am looking forward to this exciting EVOLF project!